Truvada and Tracleer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Truvada (emtricitabine; tenofovir disoproxil fumarate) and Tracleer (bosentan). Common drug interactions include headache among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Truvada and Tracleer. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Truvada?

Truvada has active ingredients of emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 76,246 Truvada users. Check the latest studies of Truvada.

What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.



On Jul, 08, 2026

26 people who take Truvada and Tracleer together, and have interactions are studied.

Truvada and Tracleer drug interactions.

What are the common drug interactions of Truvada and Tracleer, by gender? *:

female:

  1. Headache (pain in head)
  2. Face oedema (swelling of face)
  3. Lacrimation increased
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  6. Diarrhoea
  7. Hypotension (abnormally low blood pressure)
  8. Dizziness
  9. Nausea (feeling of having an urge to vomit)
  10. Portopulmonary hypertension (coexistence of portal and pulmonary hypertension)

male:

  1. Fall
  2. Balance disorder
  3. Blood creatine phosphokinase increased
  4. Faeces pale
  5. Hypotension (abnormally low blood pressure)
  6. Psychiatric symptom
  7. Suicide attempt
  8. Vomiting
  9. Dizziness
  10. Dizziness postural

What are the common drug interactions of Truvada and Tracleer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abortion induced (medically referred abortion)
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Chest pain
  4. Diarrhoea
  5. Diplopia (double vision)
  6. Drug exposure during pregnancy
  7. Epistaxis (bleed from the nose)
  8. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

40-49:

  1. Headache (pain in head)
  2. Face oedema (swelling of face)
  3. Lacrimation increased
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  6. Portopulmonary hypertension (coexistence of portal and pulmonary hypertension)
  7. Aphthous stomatitis (mouth ulcer)
  8. Back pain
  9. Cough
  10. Dehydration (dryness resulting from the removal of water)

50-59:

  1. Confusional state
  2. Fall
  3. Nausea (feeling of having an urge to vomit)
  4. Diarrhoea
  5. Drug level increased
  6. Asthenia (weakness)
  7. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Vertigo
  10. Alveolar osteitis (complication of wound healing following extraction of a tooth)

60+:

  1. Dizziness postural
  2. Fall
  3. Fluid overload (too much fluid in the blood)
  4. Memory impairment
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Pleural effusion (water on the lungs)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Respiratory disorder (respiratory disease)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Hepatitis C: 7 people, 26.92%
  2. Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 4 people, 15.38%
  3. Diarrhea: 3 people, 11.54%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 7.69%
  5. Hiv Test Positive: 2 people, 7.69%
  6. Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Truvada and Tracleer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Truvada and Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Truvada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Truvada and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tracleer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine; tenofovir disoproxil fumarate and bosentan (the active ingredients of Truvada and Tracleer, respectively), and Truvada and Tracleer (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: